{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:09:15Z","timestamp":1771924155175,"version":"3.50.1"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council, Ministry of Health Singapore","doi-asserted-by":"publisher","award":["NMRC\/CNIG\/1121\/2014"],"award-info":[{"award-number":["NMRC\/CNIG\/1121\/2014"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001353","name":"National Kidney Foundation Singapore","doi-asserted-by":"publisher","award":["NKFRC\/2016\/01\/06"],"award-info":[{"award-number":["NKFRC\/2016\/01\/06"]}],"id":[{"id":"10.13039\/501100001353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Urinary tissue inhibitor of metalloproteinase-2 (TIMP2) and insulin-like growth factor binding\nprotein-7 (IGFBP7) predict severe acute kidney injury (AKI) in critical illness. Earlier but subtle elevation of\neither biomarker from nephrotoxicity may predict drug-induced AKI.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A prospective study involving serial urine collection in patients treated with vancomycin, aminoglycosides,\namphotericin, foscarnet, or calcineurin inhibitors was performed. Urinary TIMP2 and IGFBP7, both absolute\nlevels and those normalized with urine creatinine, were examined in days leading to AKI onset by KDIGO criteria in\ncases or at final day of nephrotoxic therapy in non-AKI controls, who were matched for age, baseline kidney function,\nand nephrotoxic exposure.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Urinary biomarker analyses were performed in 21 AKI patients and 28 non-AKI matched-controls; both\ngroups had comparable baseline kidney function and duration of nephrotoxic drug therapy. Significantly higher absolute,\nnormalized, and composite levels of TIMP2 and IGFBP7 were observed in AKI cases versus controls as early as\n2-3 days before AKI onset (all P&lt;0.05); &gt;70% of patients with corresponding levels above 75th percentile developed\nAKI. Normalized TIMP2 at 2-3 days pre-AKI predicted AKI with the highest average AUROC of 0.81, followed by\nthat of composite [TIMP2]x[IGFBP7] (0.78) after cross-validation. [TIMP2]x[IGFBP7] &gt;0.01 (ng\/mL)2\/1000 predicted\nAKI with a sensitivity of 79% and specificity of 60%.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Elevated urinary TIMP2 or IGFBP7 predicts drug-induced AKI with a lead-time of 2-3 days; an opportune\ntime for interventions to reduce nephrotoxicity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389200223666220425111931","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T08:30:11Z","timestamp":1650961811000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Elevated Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth\nFactor Binding Protein-7 Predict Drug-Induced Acute Kidney Injury"],"prefix":"10.2174","volume":"23","author":[{"given":"K","family":"Akalya","sequence":"first","affiliation":[{"name":"Division of Nephrology, University Medicine Cluster, National University Hospital, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanusya Murali","family":"Murali","sequence":"additional","affiliation":[{"name":"Department of Medicine,\nYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anantharaman","family":"Vathsala","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Medicine Cluster, National University Hospital, Singapore, Singapore"},{"name":"Department of Medicine,\nYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon-Wee","family":"Teo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Medicine Cluster, National University Hospital, Singapore, Singapore"},{"name":"Department of Medicine,\nYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanmay","family":"Low","sequence":"additional","affiliation":[{"name":"Renal Unit, Department of Medicine,\nNg Teng Fong General Hospital, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmini","family":"Dharmasegaran","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Medicine Cluster, National University Hospital, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Piu","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Haematology, National University Cancer Institute,\nSingapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn Kunnath","family":"Bonney","sequence":"additional","affiliation":[{"name":"Liver Transplantation, National University Centre for Organ Transplantation, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Zhen","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Medicine Cluster, National University Hospital, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Da","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Medicine Cluster, National University Hospital, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1379-0585","authenticated-orcid":true,"given":"Horng-Ruey","family":"Chua","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Medicine Cluster, National University Hospital, Singapore, Singapore"},{"name":"Department of Medicine,\nYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12882-019-1206-4","volume":"20","author":"Low S.","year":"2019","unstructured":"Low S.; Vathsala A.; Murali T.M.; Pang L.; MacLaren G.; Ng W.Y.; Haroon S.; Mukhopadhyay A.; Lim S.L.; Tan B.H.; Lau T.; Chua H.R.; Electronic health records accurately predict renal replacement therapy in acute kidney injury. BMC Nephrol 2019,20(1),32","journal-title":"BMC Nephrol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1053\/j.ajkd.2008.11.034","volume":"53","author":"Coca S.G.","year":"2009","unstructured":"Coca S.G.; Yusuf B.; Shlipak M.G.; Garg A.X.; Parikh C.R.; Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 2009,53(6),961-973","journal-title":"Am J Kidney Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/0885066618764617","volume":"35","author":"Chua H.R.","year":"2020","unstructured":"Chua H.R.; Wong W.K.; Ong V.H.; Agrawal D.; Vathsala A.; Tay H.M.; Mukhopadhyay A.; Extended mortality and chronic kidney dis-ease after septic acute kidney injury. J Intensive Care Med 2020,35(6),527-535","journal-title":"J Intensive Care Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","volume":"39","author":"Nash K.","year":"2002","unstructured":"Nash K.; Hafeez A.; Hou S.; Hospital-acquired renal insufficiency. Am J Kidney Dis 2002,39(5),930-936","journal-title":"Am J Kidney Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","volume":"68","author":"Elyasi S.","year":"2012","unstructured":"Elyasi S.; Khalili H.; Dashti-Khavidaki S.; Mohammadpour A.; Vancomycin-induced nephrotoxicity: Mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 2012,68(9),1243-1255","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1542\/neo.13-7-e420","volume":"13","author":"Zappitelli M.","year":"2012","unstructured":"Zappitelli M.; Selewski D.T.; Askenazi D.J.; Nephrotoxic medication exposure and acute kidney injury in neonates. Neoreviews 2012,13(7),e420-e427","journal-title":"Neoreviews"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1128\/AAC.31.4.570","volume":"31","author":"Williams P.D.","year":"1987","unstructured":"Williams P.D.; Bennett D.B.; Gleason C.R.; Hottendorf G.H.; Correlation between renal membrane binding and nephrotoxicity of aminogly-cosides. Antimicrob Agents Chemother 1987,31(4),570-574","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/FTD.0b013e318286eb86","volume":"35","author":"Ram\u00edrez E.","year":"2013","unstructured":"Ram\u00edrez E.; Jim\u00e9nez C.; Borobia A.M.; Tong H.Y.; Medrano N.; Krauel-Bidwell L.; Carcas A.J.; Selgas R.; Fr\u00edas J.; Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals. Ther Drug Monit 2013,35(3),360-366","journal-title":"Ther Drug Monit"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1128\/AAC.02829-14","volume":"58","author":"Trejtnar F.","year":"2014","unstructured":"Trejtnar F.; Mand\u00edkov\u00e1 J.; Ko\u010d\u00edncov\u00e1, J.; Volkov\u00e1, M. Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals. Antimicrob Agents Chemother 2014,58(10),5650-5657","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.12659\/AOT.883229","volume":"17","author":"Gijsen V.M.","year":"2012","unstructured":"Gijsen V.M.; Madadi P.; Dube M.P.; Hesselink D.A.; Koren G.; de Wildt S.N.; Tacrolimus-induced nephrotoxicity and genetic variability: A review. Ann Transplant 2012,17(2),111-121","journal-title":"Ann Transplant"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"229S","DOI":"10.1016\/j.transproceed.2004.01.021","volume":"36","author":"Busauschina A.","year":"2004","unstructured":"Busauschina A.; Schnuelle P.; van der Woude F.J.; Cyclosporine nephrotoxicity. Transplant Proc 2004,36(2)(Suppl.),229S-233S","journal-title":"Transplant Proc"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0140-6736(10)61458-4","volume":"377","author":"Allegranzi B.","year":"2011","unstructured":"Allegranzi B.; Bagheri Nejad S.; Combescure C.; Graafmans W.; Attar H.; Donaldson L.; Pittet D.; Burden of endemic health-care-associated infection in developing countries: Systematic review and meta-analysis. Lancet 2011,377(9761),228-241","journal-title":"Lancet"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13525","volume":"33","author":"Shoham S.","year":"2019","unstructured":"Shoham S.; Dominguez E.A.; Dominguez E.A.; Emerging fungal infections in solid organ transplant recipients: Guidelines of the American society of transplantation infectious diseases community of practice. Clin Transplant 2019,33(9)","journal-title":"Clin Transplant"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1111\/j.1600-6143.2012.04245.x","volume":"12","author":"Abecassis M.","year":"2012","unstructured":"Abecassis M.; Bridges N.D.; Clancy C.J.; Dew M.A.; Eldadah B.; Englesbe M.J.; Flessner M.F.; Frank J.C.; Friedewald J.; Gill J.; Gries C.; Halter J.B.; Hartmann E.L.; Hazzard W.R.; Horne F.M.; Hosenpud J.; Jacobson P.; Kasiske B.L.; Lake J.; Loomba R.; Malani P.N.; Moore T.M.; Murray A.; Nguyen M.H.; Powe N.R.; Reese P.P.; Reynolds H.; Samaniego M.D.; Schmader K.E.; Segev D.L.; Shah A.S.; Singer L.G.; Sosa J.A.; Stewart Z.A.; Tan J.C.; Williams W.W.; Zaas D.W.; High K.P.; Solid-organ transplantation in older adults: Current status and future research. Am J Transplant 2012,12(10),2608-2622","journal-title":"Am J Transplant"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3109\/0886022X.2013.876349","volume":"36","author":"Gluhovschi G.","year":"2014","unstructured":"Gluhovschi G.; Gadalean F.; Gluhovschi C.; Velciov S.; Petrica L.; Bob F.; Bozdog G.; Kaycsa A.; Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy. Ren Fail 2014,36(4),534-540","journal-title":"Ren Fail"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.biopha.2016.09.052","volume":"84","author":"Gluhovschi G.","year":"2016","unstructured":"Gluhovschi G.; Gadalean F.; Gluhovschi C.; Velciov S.; Petrica L.; Bob F.; Bozdog G.; Kaycsa A.; Is ciprofloxacin safe in patients with solitary kidney and upper urinary tract infection? Biomed Pharmacother 2016,84,366-372","journal-title":"Biomed Pharmacother"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jinf.2009.04.003","volume":"58","author":"Yang Q.H.","year":"2009","unstructured":"Yang Q.H.; Liu D.W.; Long Y.; Liu H.Z.; Chai W.Z.; Wang X.T.; Acute renal failure during sepsis: Potential role of cell cycle regulation. J Infect 2009,58(6),459-464","journal-title":"J Infect"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/cc12503","volume":"17","author":"Kashani K.","year":"2013","unstructured":"Kashani K.; Al-Khafaji A.; Ardiles T.; Artigas A.; Bagshaw S.M.; Bell M.; Bihorac A.; Birkhahn R.; Cely C.M.; Chawla L.S.; Davison D.L.; Feldkamp T.; Forni L.G.; Gong M.N.; Gunnerson K.J.; Haase M.; Hackett J.; Honore P.M.; Hoste E.A.; Joannes-Boyau O.; Joan-nidis M.; Kim P.; Koyner J.L.; Laskowitz D.T.; Lissauer M.E.; Marx G.; McCullough P.A.; Mullaney S.; Ostermann M.; Rimmel\u00e9 T.; Shapiro N.I.; Shaw A.D.; Shi J.; Sprague A.M.; Vincent J.L.; Vinsonneau C.; Wagner L.; Walker M.G.; Wilkerson R.G.; Zacharowski K.; Kellum J.A.; Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013,17(1),R25","journal-title":"Crit Care"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bja.2018.02.069","volume":"121","author":"Su L.J.","year":"2018","unstructured":"Su L.J.; Li Y.M.; Kellum J.A.; Peng Z.Y.; Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: A meta-analysis. Br J Anaesth 2018,121(2),350-357","journal-title":"Br J Anaesth"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/ASN.2006020162","volume":"17","author":"Price P.M.","year":"2006","unstructured":"Price P.M.; Yu F.; Kaldis P.; Aleem E.; Nowak G.; Safirstein R.L.; Megyesi J.; Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 2006,17(9),2434-2442","journal-title":"J Am Soc Nephrol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"Levey A.S.","year":"2009","unstructured":"Levey A.S.; Stevens L.A.; Schmid C.H.; Zhang Y.L.; Castro A.F.; Feldman H.I.; Kusek J.W.; Eggers P.; Van Lente F.; Greene T.; Coresh J.; Ckd E.P.I.; A new equation to estimate glomerular filtration rate. Ann Intern Med 2009,150(9),604-612","journal-title":"Ann Intern Med"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012,2,1-138","journal-title":"Kidney Int Suppl"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1128\/AAC.39.3.650","volume":"39","author":"Nicolau D.P.","year":"1995","unstructured":"Nicolau D.P.; Freeman C.D.; Belliveau P.P.; Nightingale C.H.; Ross J.W.; Quintiliani R.; Experience with a once-daily aminoglycoside pro-gram administered to 2,184 adult patients. Antimicrob Agents Chemother 1995,39(3),650-655","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007484","volume":"96","author":"Liu C.","year":"2017","unstructured":"Liu C.; Lu X.; Mao Z.; Kang H.; Liu H.; Pan L.; Hu J.; Wang L.; Zhou F.; The diagnostic accuracy of urinary [TIMP-2]\u00b7[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2017,96(27)","journal-title":"Medicine (Baltimore)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1093\/jac\/dkw296","volume":"71","author":"Ong L.Z.","year":"2016","unstructured":"Ong L.Z.; Tambyah P.A.; Lum L.H.; Low Z.J.; Cheng I.; Murali T.M.; Wan M.Q.; Chua H.R.; Aminoglycoside-associated acute kidney injury in elderly patients with and without shock. J Antimicrob Chemother 2016,71(11),3250-3257","journal-title":"J Antimicrob Chemother"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.vascn.2013.11.003","volume":"69","author":"Pavkovic M.","year":"2014","unstructured":"Pavkovic M.; Riefke B.; Gutberlet K.; Raschke M.; Ellinger-Ziegelbauer H.; Comparison of the mesoscale discovery and luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model. J Pharmacol Toxicol Methods 2014,69(2),196-204","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1159\/000452592","volume":"41","author":"Luo Q.H.","year":"2016","unstructured":"Luo Q.H.; Chen M.L.; Chen Z.L.; Huang C.; Cheng A.C.; Fang J.; Tang L.; Geng Y.; Evaluation of KIM-1 and NGAL as early indicators for assessment of gentamycin-induced nephrotoxicity in vivo and in vitro. Kidney Blood Press Res 2016,41(6),911-918","journal-title":"Kidney Blood Press Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"F379","DOI":"10.1152\/ajprenal.00475.2013","volume":"306","author":"DiRocco D.P.","year":"2014","unstructured":"DiRocco D.P.; Bisi J.; Roberts P.; Strum J.; Wong K.K.; Sharpless N.; Humphreys B.D.; CDK4\/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. Am J Physiol Renal Physiol 2014,306(4),F379-F388","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1073\/pnas.1424313112","volume":"112","author":"Pabla N.","year":"2015","unstructured":"Pabla N.; Gibson A.A.; Buege M.; Ong S.S.; Li L.; Hu S.; Du G.; Sprowl J.A.; Vasilyeva A.; Janke L.J.; Schlatter E.; Chen T.; Ciarim-boli G.; Sparreboom A.; Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4\/6 and OCT2 functions. Proc Natl Acad Sci USA 2015,112(16),5231-5236","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/ndt\/gfu292","volume":"29","author":"Hoste E.A.","year":"2014","unstructured":"Hoste E.A.; McCullough P.A.; Kashani K.; Chawla L.S.; Joannidis M.; Shaw A.D.; Feldkamp T.; Uettwiller-Geiger D.L.; McCarthy P.; Shi J.; Walker M.G.; Kellum J.A.; Sapphire I.; Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014,29(11),2054-2061","journal-title":"Nephrol Dial Transplant"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","volume":"189","author":"Bihorac A.","year":"2014","unstructured":"Bihorac A.; Chawla L.S.; Shaw A.D.; Al-Khafaji A.; Davison D.L.; Demuth G.E.; Fitzgerald R.; Gong M.N.; Graham D.D.; Gunnerson K.; Heung M.; Jortani S.; Kleerup E.; Koyner J.L.; Krell K.; Letourneau J.; Lissauer M.; Miner J.; Nguyen H.B.; Ortega L.M.; Self W.H.; Sellman R.; Shi J.; Straseski J.; Szalados J.E.; Wilber S.T.; Walker M.G.; Wilson J.; Wunderink R.; Zimmerman J.; Kellum J.A.; Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014,189(8),932-939","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s11255-017-1556-4","volume":"49","author":"Toprak Z.","year":"2017","unstructured":"Toprak Z.; Cebeci E.; Helvaci S.A.; Toprak I.D.; Kutlu Y.; Sakin A.; Tukek T.; Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients. Int Urol Nephrol 2017,49(6),1041-1047","journal-title":"Int Urol Nephrol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/IJNRD.S135271","volume":"10","author":"Schanz M.","year":"2017","unstructured":"Schanz M.; Hoferer A.; Shi J.; Alscher M.D.; Kimmel M.; Urinary TIMP2-IGFBP7 for the prediction of platinum-induced acute renal injury. Int J Nephrol Renovasc Dis 2017,10,175-181","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01568-12","volume":"57","author":"van Hal S.J.","year":"2013","unstructured":"van Hal S.J.; Paterson D.L.; Lodise T.P.; Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dos-ing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother 2013,57(2),734-744","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cca.2015.10.029","volume":"452","author":"Chindarkar N.S.","year":"2016","unstructured":"Chindarkar N.S.; Chawla L.S.; Straseski J.A.; Jortani S.A.; Uettwiller-Geiger D.; Orr R.R.; Kellum J.A.; Fitzgerald R.L.; Reference inter-vals of urinary acute kidney injury (AKI) markers [IGFBP7]-[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI. Clin Chim Acta 2016,452,32-37","journal-title":"Clin Chim Acta"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ki.2010.165","volume":"78","author":"Waikar S.S.","year":"2010","unstructured":"Waikar S.S.; Sabbisetti V.S.; Bonventre J.V.; Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010,78(5),486-494","journal-title":"Kidney Int"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11622\/smedj.2015003","volume":"56","author":"Tang K.W.","year":"2015","unstructured":"Tang K.W.; Toh Q.C.; Teo B.W.; Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why. Singapore Med J 2015,56(1),7-10","journal-title":"Singapore Med J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1681\/ASN.2011040325","volume":"23","author":"Ralib A.M.","year":"2012","unstructured":"Ralib A.M.; Pickering J.W.; Shaw G.M.; Devarajan P.; Edelstein C.L.; Bonventre J.V.; Endre Z.H.; Test characteristics of urinary bi-omarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 2012,23(2),322-333","journal-title":"J Am Soc Nephrol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.kint.2016.03.031","volume":"90","author":"Goldstein S.L.","year":"2016","unstructured":"Goldstein S.L.; Mottes T.; Simpson K.; Barclay C.; Muething S.; Haslam D.B.; Kirkendall E.S.; A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 2016,90(1),212-221","journal-title":"Kidney Int"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"YE01","DOI":"10.7860\/JCDR\/2016\/18129.8744","volume":"10","author":"Bujang M.A.","year":"2016","unstructured":"Bujang M.A.; Adnan T.H.; Requirements for minimum sample size for sensitivity and specificity analysis. J Clin Diagn Res 2016,10(10),YE01-YE06","journal-title":"J Clin Diagn Res"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389200223666220425111931","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204002\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389200223666220425111931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T18:19:19Z","timestamp":1692037159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204002\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389200223666220425111931","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}